Crohn's remission generally reduces but does not eliminate GLP-1 safety concerns
ClinicalTrials.gov Coskun T, Urva S, Roell WC, et al
GLP-1 should be a tool, not a trap
, Beverly Hills Rejuvenation Center Clinical Observations For patients who are ready to transition off active treatment, we discuss maintenance dose strategies versus gradual tapering protocols, always based on your individual labs and progress
Secondly, it suppresses glucagon release , a hormone that raises blood glucose, thereby preventing excessive glucose production by the liver
Before choosing the right medication for you, it is important to check your eligibility for treatment with your doctor, insurance coverage, cost, and availability